Is alcohol consumption associated with calcified atherosclerotic plaque in the coronary arteries and aorta? - 18/08/11
, Yuqing Zhang, MD, DSc a, Paul N. Hopkins, MD, MSPH b, Sarah Knox, PhD c, Luc Djoussé, MD, DSc a, Jeffrey J. Carr, MD, MS d, eRésumé |
Background |
The goal was to investigate the relation of alcohol consumption to the presence of calcified atherosclerotic plaque in the coronary arteries (CAC) and aorta. Previous results have been conflicting, showing increases, decreases, or no effect of alcohol on risk of calcified plaque.
Methods |
We evaluated the relation of alcohol intake to presence of CAC and calcified plaque in the aorta among 3166 white and African American subjects from the NHLBI Family Heart Study who underwent cardiac computed tomography scans.
Results |
With adjustments for age, race, study center, body mass index, hyperglycemia/diabetes, hypertension, and smoking, odds ratios (and 95% CI) for CAC scores >100 in nondrinkers and consumers of 1 to 3, 4 to 7, 8 to 14, and >14 drinks per week were 1.0, 0.8 (0.4, 1.3), 1.1 (0.6, 1.9), 0.9 (0.5, 1.5), and 1.5 (0.9, 2.5), respectively, for men and 1.0, 0.9 (0.5, 1.6), 1.3 (0.8, 2.3), 1.3 (0.7, 2.2), and 2.1 (0.8, 5.9) for women. Sensitivity analyses with other cut-points for calcification gave similar results. Analyses of alcohol and aortic calcification showed similar, nonsignificant associations.
Conclusions |
Despite its frequently demonstrated beneficial effects on coronary artery disease risk, alcohol consumption in this study was not associated with calcified atherosclerotic plaque in the coronary arteries or in the aorta. This suggests that its effects on cardiovascular risk may occur through mechanisms other than those associated with the development of calcified plaque.
Le texte complet de cet article est disponible en PDF.Plan
| Support was provided by the National Heart, Lung, and Blood Institute cooperative agreement grants U01 HL 67893, U01 HL67894, U01 HL67895, U01 HL67896, U01 HL67897, U01 HL67898, U01 HL67899, U01 HL67900, U01 HL67901, and U01 HL67902, and by NIH grant AA 13304. |
Vol 152 - N° 1
P. 177-182 - juillet 2006 Retour au numéro
Article précédent
- Conjugated equine estrogens and peripheral arterial disease risk: The Women's Health Initiative
- Judith Hsia, Michael H. Criqui, David M. Herrington, JoAnn E. Manson, LieLing Wu, Susan R. Heckbert, Matthew Allison, Mary McGrae McDermott, Jennifer Robinson, Kamal Masaki, for the Women's Health Initiative Research Group
- Extent of coronary artery disease as a predictor of outcomes in acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both
- Rajesh Janardhanan, Satish Kenchaiah, Eric J. Velazquez, Yuhyun Park, John J.V. McMurray, W. Douglas Weaver, Peter V. Finn, Harvey D. White, Jose A. Marin-Neto, Chris O'Connor, Marc A. Pfeffer, Robert M. Califf, Scott D. Solomon, for the VALIANT Investigators
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?